Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection

Journal of Controlled Release

Volumn 167, Issue 1, 2013, Pages 1-10

  Sharma, Gitanjali ^a   Modgil, Amit ^a   Layek, Buddhadev ^a   Arora, Kanwardeep ^a   Sun, Chengwen ^a   Law, Benedict ^a   Singh, Jagdish ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Bi ligand; Biocompatibility; Blood brain barrier; Cell penetrating peptide; Gene delivery; Liposomes

Indexed keywords

BI-LIGAND; BLOOD-BRAIN BARRIER; CELL-PENETRATING PEPTIDE; GENE DELIVERY; HISTOLOGICAL EXAMINATION; INNOVATIVE APPROACHES; INTRAVENOUS INJECTIONS; TRANSFERRIN RECEPTORS;

AMINO ACIDS; BIOCOMPATIBILITY; BLOOD; GENE TRANSFER; LIGANDS; MOLECULAR BIOLOGY; PEPTIDES; TISSUE;

LIPOSOMES;

BETA GALACTOSIDASE; CELL PENETRATING PEPTIDE; LIGAND; LIPOSOME; TRANSFERRIN POLY LEVO ARGININE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOACCUMULATION; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROCYTE COUNT; GENETIC TRANSFECTION; HEMOLYSIS; HISTOLOGY; IN VIVO STUDY; LIPOSOMAL DELIVERY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STORAGE; ZETA POTENTIAL;

ANIMALS; BETA-GALACTOSIDASE; BRAIN; CARBOCYANINES; CELL-PENETRATING PEPTIDES; ERYTHROCYTES; FLUORESCENT DYES; HEMOLYSIS; LIGANDS; LIPOSOMES; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRANSFECTION; TRANSFERRIN;

EID: 84873449630     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.01.016     Document Type: Article

References (77)

1. M. Cavazzana-Calvo, S. Hacein-Bey, F. Yates, J.P. de Villartay, F. Le Deist, and A. Fischer Gene therapy of severe combined immunodeficiencies J. Gene Med. 3 2001 201 206
2. M. Cavazzana-Calvo, S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J.L. Casanova, P. Bousso, F.L. Deist, and A. Fischer Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672
3. M. Cavazzana-Calvo, and A. Fischer Gene therapy for severe combined immunodeficiency: are we there yet? J. Clin. Invest. 117 2007 1456 1465
4. F.P. Manfredsson, and R.J. Mandel Development of gene therapy for neurological disorders Discov. Med. 9 2010 204 211
5. L.C. Costantini, J.C. Bakowska, X.O. Breakefield, and O. Isacson Gene therapy in the CNS Gene Ther. 7 2007 93 109
6. W. Bowers, D. Howard, and H. Federoff Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease Exp. Neurol. 144 1997 58 68
7. H. Raymon, S. Thode, and F. Gage Application of ex vivo gene therapy in the treatment of Parkinson's disease Exp. Neurol. 144 1997 82 91
8. B.S. Carter, N.T. Zervas, and E.A. Chiocca Neurogenetic surgery: current limitations and the promise of gene- and virus-based therapies Clin. Neurosurg. 45 1999 226 246
9. J. Fueyo, C. Gomez-Manzano, W.K. Yung, and A.P. Kyritsis Targeting in gene therapy for gliomas Arch. Neurol. 56 1999 445 448
10. E.J. Boviatsis, J.S. Park, M. Sena-Esteves, C.M. Kramm, M. Chase, J.T. Efird, M.X. Wei, X.O. Breakefield, and E.A. Chiocca Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene Cancer Res. 54 1994 5745 5751
11. N. Haque, and O. Isacson Antisense gene therapy for neurodegenerative disease? Exp. Neurol. 144 1997 139 146
12. Y. Chen, and L. Liu Modern methods for delivery of drugs across the blood-brain barrier Adv. Drug Deliv. Rev. 64 2012 640 665
13. W.M. Pardridge Blood-brain barrier drug targeting: the future of brain drug development Mol. Interv. 3 2003 105 151
14. J. Rip, G.J. Schenk, and A.G. de Boer Differential receptor-mediated drug targeting to the diseased brain Expert Opin. Drug Deliv. 6 2009 227 237
15. W.M. Pardridge Drug and gene targeting to the brain via blood-brain barrier receptor-mediated transport systems Int. Congr. Ser. 1277 2005 49 62
16. H. Chena, L. Tanga, Y. Qina, Y. Yina, J. Tanga, W. Tanga, X. Suna, Z. Zhanga, J. Liuc, and Q. Hea Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery Eur. J. Pharm. Sci. 40 2010 94 102
17. Y. Xie, L. Ye, X. Zhang, W. Cui, J. Lou, T. Nagai, and X. Hou Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies J. Control. Release 105 2005 106 119
18. G. Sharma, A. Modgil, C. Sun, and J. Singh Grafting of Cell-Penetrating Peptide to Receptor-Targeted Liposomes Improves their Transfection Efficiency and Transport across Blood-Brain Barrier Model J. Pharm. Sci. 101 2012 2468 2478
19. Chen, G. Dalwadi, and H. Benson Drug delivery across the blood-brain barrier Curr. Drug Deliv. 1 2004 361 376
20. G. Kibria, H. Hatakeyama, N. Ohga, K. Hida, and H. Harashima Dual ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery J. Control. Release 153 2011 141 148
21. J. Cheng, B.A. Teply, I. Sherifi, J. Sung, G. Luther, F.X. Gu, E. Nissenbaum, A.F. Moreno, R. Langer, and O.C. Farokhzad Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials 28 2007 869 876
22. W.H. De Jong, W.I. Hagens, P. Krystek, M.C. Burger, A.J. Sips, and R.E. Geertsma Particle size-dependent organ distribution of gold nanoparticles after intravenous administration Biomaterials 29 2008 1912 1919
23. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822
24. A. Carlmark, C.J. Hawker, A. Hult, and M. Malkoch New methodologies in the construction of dendritic materials Chem. Soc. Rev. 38 2009 352 362
25. F. Szoka, and D. Papahadjopoulos Comparative properties and methods ofpreparation of lipid vesicles (liposomes) Annu. Rev. Biophys. Bioeng. 9 1980 467 508
26. R.H. Muller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlleddrug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
27. C. Vauthier, and K. Bouchemal Methods for the preparation and manufacture of polymeric nanoparticles Pharm. Res. 26 2009 1025 1058
28. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori K, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
29. J.K. Vasir, M.K. Reddy, and V.D. Labhasetwar Nanosystems in Drug Targeting: Opportunities and Challenges Curr. Nanosci. 1 2005 47 64
30. P.N. Shek, N.G. Lopez, and T.D. Heath Immune response mediated by liposome-associated protein antigens. IV. Modulation of antibody formation by vesicle-encapsulated methotrexate Immunology 57 1986 153 157
31. T.O. Harasyma, M.B. Ballya, and P. Tardid Clearance properties of liposomes involving conjugated proteins for targeting Adv. Drug Deliv. Rev. 32 1998 99 118
32. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237
33. M.C. Woodle, C.M. Engberg, and S. Zalipsky New amphipathic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes Bioconjug. Chem. 5 1994 493 496
34. N. Schmidt, A. Mishra, G.H. Lai, and G.C.L. Wong Arginine-rich cell-penetrating peptides FEBS Lett. 584 2010 1806 1813
35. E.L. Snyder, and S.F. Dowdy Cell penetrating peptides in drug delivery Pharm. Res. 21 2004 389 393
36. M. Lewin, N. Carlesso, C.H. Tung, X.W. Tang, D. Cory, D.T. Scadden, and R. Wessleder Tat peptide-derivatized magnetic nanoparticles allow in vivotracking and recovery of progenitor cells Nat. Biotechnol. 18 2000 410 414
37. V.P. Torchilin, R. Rammohan, V. Weissig, and T.S. Levchenko TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc. Natl. Acad. Sci. 98 2001 8786 8791
38. V.P. Torchilin, T.S. Levchenko, R. Rammohan, N. Volodina, B. Sternberg, and G.G. D'Souza Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes Proc. Natl. Acad. Sci. 100 2003 1972 1977
39. J. Huwyler, D. Wu, and W.M. Pardridge Brain drug delivery ofsmallmolecules using immunoliposomes Proc. Natl. Acad. Sci. U. S. A. 93 1996 14164 14169
40. S.R. Schwarze, A. Ho, A.V. Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572
41. I. Neundorf, R. Rennert, J. Hoyer, F. Schramm, K. Lobner, I. Kitanovic, and S. Wölf Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity Pharmaceuticals 2 2009 49 65
42. I. Nakase, Y. Konishi, M. Ueda, H. Saji, and S. Futaki Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo J. Control. Release 159 2012 181 188
43. L.N. Ramana, S. Sethuraman, U. Ranga, and U.M. Krishnan Development of a liposomal nano delivery system for nevirapine J. Biomed. Sci. 17 2010 57
44. 3-3β-bromoacetate is a stronger growth-inhibiting agent than its un-encapsulated counterpart in prostate cancer cells J. Steroids Hormon. Sci. 1 2010 101 10.4172/2157-7536.1000101
45. D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel In-vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 2003 1121 1131
46. D. Lee, K. Powers, and R. Baney Physicochemical properties and blood compatibility of acylated chitosan nanoparticles Carbohydr. Polym. 58 2004 371 377
47. B. Semete, L. Booysen, Y. Lemmer, L. Kalombo, L. Katata, J. Verschoor, and H.S. Swai In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems Nanomedicine 6 2010 662 671
48. M.T. Tseng, X. Lu, X. Duan, S.S. Hardas, R. Sultana, P. Wu, J.M. Unrine, U. Graham, D.A. Butterfield, E.A. Grulke, and R.A. Yokel Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria Toxicol. Appl. Pharmacol. 260 2012 173 182
49. S.B.M. Kanth, K. Kalishwaralal, M. Sriram, S.R. Pandian, H. Youn, S.H. Eom, and S. Gurunathan Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice J. Nanobiotechnol. 8 2010 16
50. M.A.K. Abdelhalim Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure Lipids Health Dis. 10 2011 205
51. H. Kamata, S. Tasaka, K. Inoue, K. Miyamoto, Y. Nakano, H. Shinoda, Y. Kimizuka, H. Fujiwara, M. Ishii, N. Hasegawa, R. Takamiya, S. Fujishima, H. Takano, and A. Ishizaka Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice Exp. Biol. Med. 236 2011 315 324
52. A.J. Cole, A.E. David, J. Wang, C.J. Galbán, and V.C. Yang Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles Biomaterials 32 2011 6291 6301
53. S.M. Noh, O.M. Park, G. Shim, S.E. Han, H.Y. Lee, J.H. Huh, M.S. Kim, J.J. Choi, K. Kim, I.C. Kwon, J.S. Kim, K.H. Baek, and Y.K. Oh Pegylated poly-L-arginine derivatives of chitosan for effective delivery of siRNA J. Control. Release 145 2010 159 164
54. J.A. MacKaya, D.F. Deenb, and F.C. Szoka Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter and presence of steric coating Brain Res. 1035 2005 139 153
55. J. duPlessis, C. Ramachandran, N. Weiner, and D.G.M. Oiler The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage Int. J. Pharm. 127 1996 273 278
56. Y. Xu, and F.C. Szoka Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection Biochemistry 35 1996 5616 5623
57. S. Antohi, and V. Brumfeld Polycation-cell surface interactions and plasma membrane compartments in mammals. Interference of oligocation with polycationic condensation Z. Naturforsch. C 39 1984 767 775
58. S. Zhu, F. Qian, Y. Zhang, C. Tang, and C. Yin Synthesis and characterization of PEG modified N-trimethyl amino ethyl methacrylate chitosan nanoparticles Eur. Polymer J. 43 2007 2244 2253
59. H.B. Lee, and M.D. Blaufox Blood Volume in the Rat J. Nucl. Med. 26 1985 72 76
60. V.D. Awasthi, D. Garcia, B.A. Goins, and W.T. Phillips Circulation and biodistribution profiles of long circulating PEG-liposomes of various sizes in rabbits Int. J. Pharm. 253 2003 121 132
61. E. Afergan, H. Epstein, R. Dahan, N. Koroukhov, K. Rohekar, H.D. Danenberg, and G. Golomb Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes J. Control. Release 132 2008 84 90
62. S. Deaglio, A. Capobianco, A. Cali, F. Bellora, F. Alberti, L. Righi, A. Sapino, C. Camaschella, and F. Malavasi Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum Blood 100 2002 3782 3789
63. W.A. Jefferies, M.R. Brandon, S.V. Hunt, A.F. Williams, K.C. Gatter, and D.Y. Mason Transferrin receptor on endothelium of brain capillaries Nature 312 1984 162 163
64. S.A.L. Audouy, L.F.M.H. de Leiji, D. Hoekstra, and G. Molema In vivo characteristics of cationic liposomes as delivery vectors for gene therapy Pharm. Res. 19 2002 1599 1605
65. H. Ishiwata, N. Suzuki, S. Ando, H. Kikuchi, and T. Kitagawa Characteristics and biodistribution of cationic liposomes and their DNA complexes J. Control. Release 69 2000 139 148
66. D. Mudhakir, H. Akita, I.A. Khalil, S. Futaki, and H. Harashima Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice Drug Metab. Pharmacokinet. 20 2005 275 281
67. Y. Hayashi, J. Yamauchi, I.A. Khalil, K. Kajimoto, H. Akita, and H. Harashima Cell penetrating peptide-mediated systemic siRNA delivery to the liver Int. J. Pharm. 419 2011 308 313
68. Z.M. Qian, H. Li, H. Sun, and K. Ho Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway Pharmacol. Rev. 54 2002 561 587
69. H.H. Kim, H.S. Choi, J.M. Yang, and S. Shin Characterization of gene delivery in vitro and in vivo by the arginine peptide system Int. J. Pharm. 335 2007 70 78
70. U. Guliyeva, F. Oner, S. Ozsoy, and R.H. Lu Chitosan microparticles containing plasmid DNA as potential oral gene delivery system Eur. J. Pharm. Biopharm. 62 2006 17 25
71. H. Zhao, G.L. Li, R.Z. Wang, S.F. Li, J.J. Wei, M. Feng, Y.J. Zhao, W.B. Ma, Y. Yang, Y.N. Li, and Y.G. Kong A comparative study of transfection efficiency between liposomes, Immunoliposomes and brain-specific immunoliposomes J. Int. Med. Res. 38 2010 957 966
72. N. Shi, R.J. Boado, and W.M. Pardridge Receptor-mediated gene targeting to tissues in vivo following intravenous administration of Pegylated immunoliposomes Pharm. Res. 18 2001 1091 1095
73. Y. Lee, A. Messing, M. Su, and M. Brenner GFAP promoter elements required for region-specific and astrocyte-specific expression Glia 56 2008 481 493
74. K. Prabhakara, S.M. Afzala, P.U. Kumarb, A. Rajannab, and V. Kishana Brain delivery of transferrin coupled indinavir submicron lipid emulsions - Pharmacokinetics and tissue distribution Colloids Surf. B 86 2011 305 313
75. A. Bolhassani Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer Biochim. Biophys. Acta 1816 2011 232 246
76. S.W. Jones, R. Christison, K. Bundell, C.J. Voyce, S.M.V. Brockbank, P. Newham, and M.A. Lindsay Characterisation of cell-penetrating peptide-mediated peptide delivery Br. J. Pharmacol. 145 2005 1093 1102
77. L. Guo, L. Fan, Z. Pang, J. Ren, Y. Ren, J. Li, J. Chen, Z. Wen, and X. Jiang TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes J. Control. Release 154 2011 93 102